SCHEMBL7795669

SCHEMBL7795669

COc1cc(OC)c2c(c1)C(=O)c1cccc(OCCCN3CCOCC3)c1-2

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
CYP2D6 P10635 1/20 0.57
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
KDM4E B2RXH2 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
CHEK1 O14757 2/20 0.49
USP2 O75604 1/20 0.48
SRC P12931 1/20 0.47
KDR P35968 1/20 0.47
BCL9 O00512 1/20 0.47
CTNNB1 P35222 1/20 0.47
KEAP1 Q14145 2/20 0.47
NFE2L2 Q16236 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786493 0.96 TSHR (0.57) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL7791821 0.95 CHEK1 (0.50) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL7796485 0.91 TSHR (0.49) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL7796613 0.91 HRH3 (0.52) CYP2D6ALDH1A1KDM4E
SCHEMBL7792140 0.90 CYP2D6 (0.65) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL7786095 0.90 HRH3 (0.54) CYP2D6ALDH1A1KDM4E
SCHEMBL7792479 0.89 CHEK1 (0.49) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL7796256 0.89 CHEK1 (0.49) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1
SCHEMBL27493228 0.89 HRH3 (0.50) CYP2D6ALDH1A1KDM4E
SCHEMBL27495200 0.88 TSHR (0.45) TSHRCYP2D6ALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906268-B1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS AVENTIS PHARMA INC (US) 2001-11-28 EP disclosed
US-6004959-A HYPOTENSIVE, ANTITUMOR, ANTIINFLAMMATORY AND ANTIASTHMATIC AGENTS; ANGIOGENESIS AND ALVEOLAR MACROPHAGE ACTIVATION INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1999-12-21 US disclosed